Encompass Health price target raised to $95 from $93 at Mizuho

Mizuho raised the firm’s price target on Encompass Health to $95 from $93 and keeps a Buy rating on the shares. The company reported one of the strongest quarters in its history with an all-around beat, the analyst tells investors in a research note. Given the strong fundamentals in the inpatient rehabilitation business, continued improvement in labor trends, bed expansion strategy, and acquisitions, the firm continues to believe the visibility is strong for Encompass.